![Prescribing Information for Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors (Based on US Labels) | Radcliffe Cardiology Prescribing Information for Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors (Based on US Labels) | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2021-03/table2-prescribing-information.png)
Prescribing Information for Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors (Based on US Labels) | Radcliffe Cardiology
![Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients](https://diatribe.org/cdn-cgi/image/width=400/sites/default/files/images/GPEN%20Mini%20Model%20Xeris.jpg)
Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients
![Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia](https://diatribe.org/sites/default/files/gpen.jpg)
Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
![GVOKE (glucagon injection) Xeris Pharmaceuticals, Inc. These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE. GVOKE (glucagon injection), for subcutaneous GVOKE (glucagon injection) Xeris Pharmaceuticals, Inc. These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE. GVOKE (glucagon injection), for subcutaneous](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=72065-121-11_AI_Pouch_1mg.jpg&id=685359)
GVOKE (glucagon injection) Xeris Pharmaceuticals, Inc. These highlights do not include all the information needed to use GVOKE safely and effectively. See full prescribing information for GVOKE. GVOKE (glucagon injection), for subcutaneous
GLUCAGON AGENTS; Current Product Listing. LABEL NAME GENERIC NAME MANUFACTURER DRUG TYPE PROVIDER SYNERGIES BRAND NAME ROUTE BAQ
![Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation | Diabetes Technology & Therapeutics Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2019.0148/asset/images/medium/figure2.gif)